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Abstract
Interferon (IFN)-gamma is highly expressed in atherosclerotic lesions and may
have an important role in atherogenesis. Myeloperoxidase (MPO), the most
abundant protein in neutrophils, is a marker of plaque vulnerability and a
possible bridge between inflammation and cardiovascular disease.
Granulocyte-macrophage colony-stimulating factor (GM-CSF) has also been
implicated in the pathogenesis of atherosclerosis. The present study investigated
the role of neutrophil activation in atherosclerosis. Adherent macrophages were
obtained from primary cultures of human mononuclear cells. Expression of
IFN-gamma protein by GM-CSF-dependent-macrophages was investigated by
enzyme-linked immunosorbent assay after stimulation with MPO. GM-CSF
enhanced macrophage expression of the mannose receptor (CD206), which is
involved in MPO uptake. MPO increased IFN-gamma production by
GM-CSF-dependent macrophages in a concentration-dependent manner.
Pretreatment of macrophages with small interfering RNA (siRNA) for CD206 or
extracellular signal-regulated kinase (ERK)-2 attenuated IFN-gamma production,
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while siRNA for ERK-1 did not. GAPDH is known to bind to adenylate/
uridylate (AU)-rich elements of RNA and may influence IFN-gamma protein
expression by binding to the AU-rich element of IFN-gamma mRNA.
Interestingly, pretreatment with siRNA for GAPDH significantly reduced
IFN-gamma production by macrophages, while it did not affect TF protein
expression. In conclusion, MPO upregulates IFN-gamma production by
GM-CSF-dependent-macrophages via the CD206/ERK-2 signaling pathway,
while silencing GAPDH reduces IFN-gamma production.
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1. Introduction
Myeloperoxidase (MPO) has emerged as a potential participant in the development
of atherosclerosis. Extracellular release of MPO after neutrophil activation is a
marker of plaque vulnerability and MPO has been proposed as a bridge between
inflammation and cardiovascular disease since elevated circulating levels of MPO
are associated with an enhanced risk of major adverse cardiac events [1].
Interferon (IFN)-gamma also is a key regulator of immune function that is
highly expressed in atherosclerotic lesions and may have a significant role in
atherogenesis. However, the influence of IFN-gamma on atherogenesis is
complex, with both pro-atherogenic and anti-atherogenic actions being
identified. It has been reported that IFN-gamma induces arteriosclerotic changes
in the absence of immunocytes by acting on vascular smooth muscle cells
(VSMCs) to potentiate growth-factor-induced mitogenesis [2].
Atherosclerotic lesions contain a large number of immune cells, particularly
macrophages and T cells [3]. Activation of macrophages and T cells by
pro-inflammatory stimuli causes switching of metabolism towards glycolysis and
away from oxidative phosphorylation [4,5]. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) is a multifunctional protein, and its expression and
activity can be affected by disease states and/or experimental manipulation.
Expression of GAPDH has been reported to be altered in certain tumors, as
well as in proliferating and differentiating cells [6]. While GAPDH was long
considered to be a classical glycolytic enzyme exclusively involved in
cytosolic energy production, extra-glycolytic functions of GAPDH have been
described, including regulation of protein expression via RNA binding [7]. RNA
elements rich in adenine and uracil residues (AU-rich elements) bind with
specific proteins that either direct the RNA to degradation or not, and GAPDH
is a non-canonical AU-rich RNA- binding protein [7]. This suggests that
GAPDH may play a role in regulating RNA expression and cytokine
production. Removal of the AU-rich element from interferon (IFN)-gamma has
been reported to promote chronic elevation of circulating serum IFN-gamma
Article No~e00080
2 http://dx.doi.org/10.1016/j.heliyon.2016.e00080
2405-8440/© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
levels [8]. Regulation of mRNA decay is a major control point in gene
expression. The expression of a particular mRNA is controlled by specific
interactions between its structural elements and RNA-binding proteins that can
be general or mRNA-specific [9]. AU-rich elements are one of the most
common factors regulating RNA expression in mammalian cells [10]. An
AU rich element in the 3' noncoding region promotes rapid degradation of
mammalian cytokine and proto-oncogene mRNAs [11].
Atherosclerosis is a chronic and progressive inflammatory disease characterized
by accumulation of lipids and fibrous plaques in the intimal layer of the walls
of large arteries. Macrophages play a pivotal role in both the initiation and the
progression of atherosclerosis [12, 13]. There is increasing evidence that plaque
macrophages have a dynamic role and that both macrophage numbers and their
expression of the inflammatory phenotype influence plaque fate. GM-CSF
may be involved in the pathogenesis of atherosclerosis and other chronic
inflammatory diseases since it is found in atherosclerotic plaques and promotes
aortic lipid accumulation. A key component of chronic inflammation in
atherosclerotic plaques is persistent influx of mononuclear phagocytes, which
are the major leukocyte population in atherosclerotic lesions [14]. When
cultured with GM-CSF, murine macrophages undergo differentiation into
low-density lipoprotein (LDL)-rich foam cells [15].
We previously reported that IFN-γ mRNA expression by monocytes was increased
after exposure to neutrophil extracellular traps in the Transwell assay. In addition,
MPO significantly increased IFN-gamma protein production by monocytes
compared with HNE, proteinase-3, and cathepsin G [16]. MPO is a ligand cleared
by the mannose receptor (CD206) and macrophages express CD206. Therefore,
this study was performed to investigate the effect of either MPO or GAPDH on
IFN-gamma production by GM-CSF-dependent macrophages.
2. Materials and methods
2.1. Ethics statement
Human peripheral blood samples were obtained from healthy volunteers and this
study was approved by the Institutional Review Board of Kumamoto Health
Science University. Written informed consent was obtained from all of the
volunteers.
2.2. Chemicals and reagents
Myeloperoxidase (MPO) was purchased from Athens Research and Technology
(Athens, GA). All reagent solutions were negative for endotoxin by the
Endospecy test [17].
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2.3. Isolation of adherent monocytes from peripheral blood
mononuclear cells
Lymphocyte thawing medium (BBLYMPH1) was obtained from Zen-Bio, Inc.
(Research Triangle Park, NC). Peripheral blood mononuclear cells (PBMCs)
were isolated as described previously [18]. Briefly, heparinized blood samples
were obtained from nonsmoking healthy volunteers and were diluted 1:1 with
pyrogen-free saline. PBMCs were isolated immediately after blood collection
by using Lymphoprep gradients (Axis-Shield PoC As, Norway) and were
suspended in BBLYMPH1 and incubated for 3 h. For isolation of monocytes
from PBMCs by adherence to plastic, cells (1 × 106 per well) were distributed
into 12-well plates (Corning Inc. Costar, NY, USA) and allowed to adhere in a
5% CO2 incubator at 37 °C for 2 h, followed by washing 3 times with warm
phosphate-buffered saline (PBS) to remove nonadherent cells. Then the
monocytes thus obtained were cultured in complete medium consisting of
RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS) and
10 × 103 μg/L gentamicin at 37 °C in humidified air with 5% CO2. Adherent
monocytes were recovered with a cell scraper and the purity of these cells was
evaluated by FACS analysis after staining with a phycoerythrin-conjugated
mouse anti-human CD14 monoclonal antibody (Life Technologies, Staley Road
Grand Island, NY). The monocytes were also evaluated by trypan blue staining
and counting under a Zeiss microscope (Jena, Germany). Only CD14+
monocytes with >85% purity were used for each experiment.
2.4. Differentiation of adherent monocytes into macrophages
Adherent monocytes (1 × 106 cells/mL) were seeded into 12-well tissue
culture plates containing RPMI-1640 medium with 10% FCS and 4 mM
L-glutamine, and were incubated in the presence of recombinant human
GM-CSF (10 × 103 ng/L; Tocris Bioscience, Bristol, UK) [19]. On days 3 and
6 of culture, the cells were washed and fresh medium containing GM-CSF
was added. After further incubation until day 9, the cells were utilized as
GM-CSF-dependent macrophages [20].
2.5. Enzyme-linked immunosorbent assay (ELISA) for
interferon (IFN)-gamma
Monocytes (1 × 106 cells) and GM-CSF-dependent macrophages (1 × 106 cells)
were stimulated with MPO (0, 20, 50, or 100 × 103 mU/L) for 6 h and
IFN-gamma protein levels in whole-cell lysates were determined by ELISA
(Santa Cruz Biotechnology, Santa Cruz, CA) with an anti-IFN-gamma
monoclonal antibody.
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2.6. Western blotting for the mannose receptor (CD206)
On days 0, 1, 3, 5, 7, and 9 of culture, CD206 protein was detected in
GM-CSF-dependent macrophages (1 × 106 cells) by western blotting. Equivalent
amounts of whole-cell lysates were subjected to electrophoresis and the products
were transferred to polyvinylidene difluoride membranes. The membranes were
incubated with 0.5 × 103 μg/L mouse anti-human CD206 IgG (Santa Cruz
Biotechnology), washed, and incubated with alkaline phosphatase-conjugated
goat anti-mouse IgG (Santa Cruz Biotechnology) diluted to 1:4000. Then the
membranes were incubated with chemiluminescent enhancer (Immun-Star,
Bio-Rad, Hercules, California) and exposed to XAR film (Kodak, Rochester,
NY). After the film was developed, bands were quantified with a densitometer
and ImageQuant software (Molecular Dynamics, Sunnydale, CA). Human whole
cell lysate was utilized as a positive control (Santa Cruz Biotechnology).
2.7. Transfection with small interfering RNA (siRNA)
siRNA duplexes (siRNAs) of extracellular signal-regulated kinase (ERK)-1,
ERK-2, and CD206 were purchased from Santa Cruz Biotechnology.
Transfection of siRNAs (50 nM) into GM-CSF-dependent macrophages on days
7 and 8 of culture was performed according to the manufacturer’s protocol for
LipofectamineTM RNAiMAX (Life Technologies). siRNA for GAPDH was
utilized as a negative control.
[(Fig._1)TD$FIG]
Fig. 1. IFN-gamma protein levels in monocytes and GM-CSF-dependent macrophages after
stimulation with myeloperoxidase (MPO). Monocytes (1 × 106 cells) and GM-CSF-dependent
macrophages on day 9 of culture (1 × 106 cells) were stimulated with MPO (0, 20, 50 or 100 × 103
mU/L) for 6 h. Whole-cell lysates of GM-CSF-dependent macrophages contained significantly
higher levels of IFN-gamma than lysates of monocytes and the effect of MPO was concentration-
dependent. IFN: interferon, GM-CSF: granulocyte-macrophage colony-stimulating factor, MPO:
myeloperoxidase.
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On day 9, transfected cells (1 × 106) were stimulated with MPO
(50 × 103 mU/L) for 6 h and then IFN-gamma protein levels in whole-cell
lysates were determined by ELISA (Abcam Inc.) with an anti-IFN-gamma
monoclonal antibody. The tissue factor protein level in whole-cell lysates was
also determined by ELISA (Abcam Inc.) with an anti-tissue factor monoclonal
antibody as an unrelated control.
2.8. Statistical analysis
Results are expressed as the mean ± SE. Analysis of variance and the t-test for
independent mean values were used to assess differences between multiple
groups and differences between two groups, respectively. When the F ratio was
found to be significant, mean values were compared by a post hoc Bonferroni
test. A probability (P) value <0.05 was considered to indicate significance in all
analyses.
[(Fig._2)TD$FIG]
Fig. 2. Western blotting for CD206. CD206 expression by GM-CSF-dependent macrophages
(1 × 106 cells) on day 0, 1, 3, 5, 7, and 9 of culture was detected by western blotting.
CD206: mannose receptor (cluster of differentiation 206), GM-CSF: granulocyte-macrophage
colony-stimulating factor. Data were obtained by using samples from three volunteers in each group
and a representative result is shown as arbitrary density units. (a) Representative blot. (b) Arbitrary
density data. Human whole cell lysate was utilized as a positive control.
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3. Results
Incubation with MPO resulted in a concentration-dependent increase of
IFN-gamma production by GM-CSF-dependent macrophages. IFN-gamma
protein levels were also significantly higher in macrophages than in monocytes
(Fig. 1). Western blotting showed that expression of mannose receptor (CD206)
protein by GM-CSF-dependent macrophages increased a time-dependent
manner during culture (Fig. 2). Transfection of macrophages with siRNA for
GAPDH reduced the level of GAPDH protein detected by western blotting
(Fig. 3). Transfection with siRNA for extracellular signal-regulated kinase-2
(ERK-2) attenuated IFN-gamma production after stimulation with MPO, but
siRNA for ERK-1 did not affect it. Transfection with siRNA for CD206 also
significantly reduced IFN-gamma production. Interestingly, IFN-gamma
production by GM-CSF-dependent macrophages stimulated with MPO was
significantly attenuated after transfection with the siRNA for GAPDH. In
contrast, tissue factor (TF) expression was not affected by silencing of
GAPDH with siRNA (Fig. 4).
[(Fig._3)TD$FIG]
Fig. 3. Western blotting for glyceraldehyde 3-phosphate dehydrogenase (GAPDH). GAPDH protein
was detected by western blotting in whole-cell lysates of GM-CSF-dependent macrophages (day 9)
with or without transfection of siRNA for GAPDH. GAPDH: glyceraldehyde 3-phosphate
dehydrogenase. Data were obtained by using macrophages from three volunteers in each group and
a representative result is shown as arbitrary density units.
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[(Fig._4)TD$FIG]
Fig. 4. Effect of small interfering RNA (siRNA) on IFN-gamma production. IFN-gamma protein
levels in whole-cell lysates of GM-CSF-dependent macrophages (day 9) transfected with siRNAs
for GAPDH, ERK-1, ERK-2, or CD206 were determined by ELISA after stimulation with MPO
(50 × 103 mU/L) (a). In addition, tissue factor (TF) protein levels in whole-cell lysates of
GM-CSF-dependent macrophages (day 9) transfected with siRNAs for GAPDH, ERK-1, ERK-2, or
CD206 were determined by ELISA after stimulation with MPO (50 × 103 mU/L) (b). ERK:
extracellular signal-regulated kinase, CD206: mannose receptor (cluster of differentiation 206),
GAPDH: glyceraldehyde 3-phosphate dehydrogenase, GM-CSF: granulocyte-macrophage
colony-stimulating factor), TF: tissue factor. Data were obtained by using macrophages from three
volunteers in each group and are represented as the mean ± SE. *P [3_TD$DIFF][1_TD$DIFF]<0.01; **P<0.05; N.S., not
significant.
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4. Discussion
The present study demonstrated that stimulation of GM-CSF-dependent
macrophages with MPO resulted in significant elevation of the IFN-gamma protein
level compared with that in monocytes. This study also clearly demonstrated that
expression of CD206 by cultured GM-CSF-dependent macrophages increased over
time. Furthermore, we found that MPO stimulated IFN-gamma production, while
it was significantly reduced by pretreatment with siRNAs for CD206 or GAPDH.
Our findings suggest that GAPDH may influence atherosclerosis through
stabilizing IFN-gamma production by macrophages.
CD206 has been shown to be essential for the production of both pro-inflammatory
and anti-inflammatory cytokines. Furthermore, CD206 is an important pattern
recognition receptor of the innate immune system [21] and it might interact with
other pattern recognition receptors to mediate intracellular signaling [22, 23].
Moreover, C-type lectins have a direct effect on signaling pathways, including
activation of mitogen-activated protein kinases (MAPKs) and nuclear-factor kappa
B (NF-kB) [24]. In the present study, MPO stimulated IFN-gamma production by
GM-CSF-dependent macrophages, while it was significantly attenuated by
transfection of siRNA for CD206. The MAPKs are serine/threonine protein
kinases that regulate diverse cellular programs by relaying extracellular signals and
they include the extracellular signal-regulated kinases 1/2 (ERK1/2), c-Jun amino
(N)-terminal kinases 1/2/3 (JNK1/2/3), p38 isoforms (alpha, beta, gamma, and
delta), and ERK5 [25]. The ERK cascade is a central pathway involved in
transmitting signals from many extracellular agents to regulate cellular processes,
with ERK1 and ERK2 being dual-specificity protein kinases that control cell
growth and differentiation. In the present study, siRNA for ERK-2 attenuated
IFN-gamma production by GM-CSF-dependent macrophages after stimulation
with MPO, while ERK-1 siRNA had no effect.
We utilized siRNA for GAPDH as a negative control. Unexpectedly, we found
that pretreatment of macrophages with siRNA for GAPDH significantly
attenuated IFN-gamma production after stimulation with MPO. GAPDH is
generally thought of as an enzyme that only has an important role in glycolysis,
and is used as a housekeeping gene for measurement of equal loading in many
experiments. Interestingly, it has been reported that GAPDH binds to the
adenylate/uridylate-rich (AU-rich) element of the 3' untranslated region of
macrophage colony-stimulating factor RNA [26]. AU-rich elements are one of
the most common determinants of RNA expression in mammalian cells [27] and
are often targeted for rapid mRNA degradation [28, 29]. In addition, Chang
et al. [30] reported that GAPDH directly regulates IFN-gamma protein
expression in CD4+ T cells and that this interaction takes place at the 3'UTR,
where binding of GAPDH prevents translation of the mRNA sequence. Thus,
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GAPDH is a multifunctional protein that binds mRNAs to regulate stability as
part of its repertoire [31]. In the present study, silencing GAPDH did not affect
TF production, although TF mRNA contains AU-rich elements. Thus, we
demonstrated a differential effect of GAPDH on IFN-gamma or TF production
by macrophages that requires further investigation. We found that transfection of
macrophages with siRNA for GAPDH resulted in a decline of IFN-gamma
production. Both GAPDH and heat shock protein 70 have been reported to bind
to the AU-rich element of IFN-gamma [32, 33]. In contrast, TF production was
not affected by transfection with siRNA for GAPDH, suggesting that GAPDH is
involved in regulating the immune and inflammatory responses of macrophages.
5. Conclusion
The present findings suggested that GAPDH may have a role in regulating the
production of IFN-gamma by macrophages.
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